Unraveling the Mystery: Could Copper Disruption Be the Missing Link in MS Risk Factors?
Multiple sclerosis (MS) is a debilitating condition that affects thousands of Australians, and the search for effective treatments and prevention strategies is an ongoing challenge. But here's where it gets controversial: a recent research grant from MS Australia has shed light on a potential connection between copper disruption and key MS risk factors, offering a glimmer of hope for those affected by this disease.
MS is an autoimmune disorder where the body's immune system mistakenly attacks the brain and spinal cord, leading to damage of the myelin sheath that protects nerve fibers. This can result in a range of symptoms, from mobility issues to cognitive impairment and fatigue. The number of Australians living with MS has been steadily rising, with over 37,700 cases in 2025, a significant increase from 2010. The economic burden of MS is also substantial, reaching $3 billion in 2024.
One of the featured projects in the grant is led by Dr. Brittney Lins, a Postdoctoral Fellow at Curtin University and Perron Institute. Dr. Lins is investigating whether disrupted copper levels in the brain may be linked to major MS risk factors, including Epstein-Barr virus infection, vitamin D deficiency, and gut health. The project aims to explore whether copper imbalance contributes to myelin damage, with the ultimate goal of identifying new prevention and treatment strategies.
"Copper is a trace nutrient that we obtain through food, and although it is present in very low levels in the body, it plays a critical role in energy utilization and antioxidant defenses," explains Dr. Lins. "If copper use is disrupted, myelin may be more vulnerable to inflammation and autoimmunity. I believe copper could be the missing link that ties together multiple MS risk factors."
Dr. Rebekah Puls, Head of Research at Perron Institute, adds, "Dr. Lins has been awarded a prestigious fellowship to pursue an exciting preclinical project. Recent advances in technology now make it possible to image copper levels in the brain using cutting-edge synchrotron microscopy, opening the door to discoveries that were previously out of reach."
The project collaborators include Associate Professor Mark Hackett from Curtin University and the Neurotrauma Research group, comprising Professor Lindy Fitzgerald, Dr. Sarah Hellewell, and Dr. Chidozie Anyaegbu. Over the past two decades, MS Australia has invested more than $60 million in MS research, with CEO Rohan Greenland emphasizing the importance of sustained national investment in research to drive progress for people living with MS. "Research is hope, and it reminds people living with MS that progress is possible, and that better treatments and prevention are within reach," he said.
The research grants will be formally launched at Parliament House in Canberra on March 4th at MS Australia's Advancing MS Research in Australia event, with prominent speakers including Dr. Monique Ryan MP and Ms. Renee Coffey MP, who will highlight the significance of a sustained national commitment to MS research. But here's the part most people miss: the potential implications of this research could spark a new era of MS treatment and prevention, and we want to hear your thoughts! Do you agree or disagree with the findings? Share your opinions in the comments below.
